1. Market Research
  2. > Pharmaceutical
  3. > Generic Drug Market Trends
  4. > World Generic Markets 20 OCTOBER 2014

World Generic Markets 20 OCTOBER 2014

  • October 2014
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Leaked TPP Document Reveals Pharmaceutical Policy Disputes Remain
Industry Brief - Impax To Acquire Tower Holdings And Subsidiaries
Industry Trend Analysis - Congress Probes Generic Drug Pricing
Industry Brief - Synthon Files Glatiramer ANDA With FDA
Industry Brief - Sucampo Settles US Amitiza Litigation; Receives New Challenger
Industry Brief - New Generic Threat To Trokendi XR Revealed
Industry Brief - Breckenridge Launches Mefanamic Acid In US
Industry Brief - Noven Files Paroxetine Lawsuit Against Actavis
Industry Brief - Actavis Initiates Methylphenidate Patent Challenge
Industry Trend Analysis - WHO BQ Proposal Gains Traction, But EGA Response Delivers Stumbling Block
Industry Brief - STADA In-Licenses Biosimilar Teriparatide
Industry Trend Analysis - USTR Initiates India Review In A Changed Political Landscape
Industry Brief - Cipla Bolsters Presence In Kenya
Industry Brief - Cipla Medpro Teams Up With Teva In South Africa
Industry Trend Analysis - Stalled Patent Reforms Would Increase Access To Essential Medicines

Table Of Contents

World Generic Markets 20 OCTOBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...

Global Febuxostat Market Research Report 2016

Global Febuxostat Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Febuxostat Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Febuxostat industry, focusing on the main regions (North America, ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.